Related Experiment Video
Updated: Aug 17, 2026
Identification of Kinase-substrate Pairs Using High Throughput Screening
Published on: August 29, 2015
Kinase substrate protein microarray analysis of human colon cancer and hepatic metastasis
Claudio Belluco1, Enzo Mammano, Emanuel Petricoin
1Department of Oncological and Surgical Science, Surgery Branch, University of Padova, Padova, Italy. claudio.belluco@unipd.it
Background:
Liver metastases represent the major determinant of survival in patients with colorectal cancer (CRC). In cases with unresectable liver disease, more effective agents are needed, since chemotherapy achieves median survival of only 15 months. Protein kinases coordinate complex functions that are often disregulated in cancer and are therefore considered important targets for molecular therapeutics. In this study, we investigated the phosphoproteomic status of different protein kinases in primary CRC and in liver metastases.
Methods:
The status of 29 key endpoints was evaluated using reverse phase protein array on laser capture microdissected neoplastic cells from five primary CRCs without metastases, three patient-matched primary CRCs and synchronous liver metastases and five CRC metachronous liver metastases.
Results:
Unsupervised hierarchical two-way clustering analysis showed an entirely different phosphoproteomic profile in primary CRCs compared to liver metastases. This difference was observed also in primary and metastatic patient-matched lesions.
Conclusions:
Our findings of different signaling pathways between primary and metastatic CRC suggest a possible microenvironment effect, and emphasize the need to perform molecular network analysis of metastatic tissue when molecular targeting is considered.
Insights
Colorectal cancer (CRC) liver metastases have distinct protein kinase signaling compared to primary tumors. This highlights the need to analyze metastatic tissue for effective molecular targeting in advanced CRC.
Area of Science:
- Oncology
- Molecular Biology
- Proteomics
Background:
- Liver metastases are a primary cause of mortality in colorectal cancer (CRC).
- Current chemotherapy offers limited survival benefits for unresectable liver disease.
- Protein kinases are crucial in cancer signaling and represent therapeutic targets.
Purpose of the Study:
- To investigate differences in protein kinase phosphoproteomic status between primary CRC and liver metastases.
- To identify potential therapeutic targets based on molecular differences.
Main Methods:
- Utilized reverse phase protein array (RPPA) on laser capture microdissected neoplastic cells.
- Analyzed 29 key protein endpoints in primary CRCs and matched liver metastases.
- Compared phosphoproteomic profiles of primary tumors, synchronous, and metachronous metastases.
Main Results:
- Unsupervised hierarchical clustering revealed distinct phosphoproteomic profiles between primary CRCs and liver metastases.
- These differences were evident even in patient-matched primary and metastatic lesions.
- Signaling pathways differ significantly between primary and metastatic colorectal cancer.
Conclusions:
- The distinct signaling pathways suggest a significant microenvironment influence on CRC metastasis.
- Molecular network analysis of metastatic tissue is crucial for developing targeted therapies.
- Future research should focus on understanding and targeting metastatic-specific pathways.
